Cost Effective SPR BiOptix’s 404pi delivers label-free, real-time biomolecular interaction analysis with outstanding sensitivity and low noise, at a price point hundreds of thousands of dollars less than comparable systems. This enables cost-conscious academic labs, biotech startups, and core facilities to upgrade to high-performance SPR without breaking the budget, accelerating adoption through favorable total cost of ownership and faster ROI.

Trusted Credibility Partner ESPR technology developed with Nobel Prize-winning Dr. John Hall provides a strong credibility signal when engaging procurement and grant committees. Leverage co-branded materials, white papers, and joint webinars to differentiate BiOptix from larger incumbents and win pilot programs and collaborations.

Broad Market Applications Instrumentation supports diverse workflows including protein-protein, protein-small molecule, and antibody-antigen interactions, with capabilities for kinetic rate measurements, fragment screening, epitope mapping, and affinity analysis. This breadth enables tailored pitches to pharma CROs for screening and early discovery, as well as academic labs pursuing fundamental binding studies.

Strategic Partnerships Channel Given the small team, prioritize channel partnerships with distributors, academic core facilities, and CRO networks to scale reach and service. Develop reseller agreements, bundled training packages, and on-site installation support to reduce entry barriers and accelerate deployment in new regions.

Trial Programs Offer pilot evaluations or discounted trials to qualified labs, with onboarding support and software configuration to demonstrate rapid value. Pair trials with training and a short-term service contract to convert pilots into long-term customers, while generating case studies to fuel broader marketing.